Heron Therapeutics reported $-41176000 in EBITDA for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Ebitda Change
Alnylam Pharmaceuticals ALNY:US USD -174303000 73.14M
Amarin AMRN:US USD 2.2M 39.04M
Ani Pharmaceuticals ANIP:US USD 18.96M 7.06M
Anika Therapeutics ANIK:US USD -2947000 644K
Arrowhead Research ARWR:US USD -39434000 41.74M
Eisai 4523:JP JPY 18.72B 11.02B
Emergent Biosolutions EBS:US USD -22600000 15M
Endo International Ordinary Shares ENDP:US USD 151.76M 22.28M
Esperion Therapeutics ESPR:US USD -42421000 903K
GlaxoSmithKline GSK:LN GBP 1.6B 1.76B
Heron Therapeutics HRTX:US USD -41176000 7.65M
Immunogen IMGN:US USD -59131000 17.87M
Insmed INSM:US USD -149714000 29.85M
JAZZ PHA JAZZ:US USD -118655000 466.69M
Ligand Pharmaceuticals LGND:US USD -11560000 25.67M
Nektar Therapeutics NKTR:US USD -37707000 2.91M
Neurocrine Biosciences NBIX:US USD 107.8M 16M
Omeros OMER:US USD -39975000 10.47M
Pacira Pharmaceuticals PCRX:US USD 44.76M 2.79M
Roche Holding ROG:VX 10.43B 3B
Sangamo Biosciences SGMO:US USD -52049000 204K
Surmodics SRDX:US USD -5107000 734K
Teva Pharmaceutical Industries TEVA:US USD 1.31B 245M
Ultragenyx Pharmaceutical RARE:US USD -140671000 79.7M
Veracyte VCYT:US USD 1.14M 4.49M